Enterprise Value
-448K
Cash
303.3M
Avg Qtr Burn
-13.57M
Short % of Float
19.04%
Insider Ownership
9.31%
Institutional Own.
93.06%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
JANX007 (PSMA-TRACTr) Details Cancer, Prostate cancer, Castration-resistant prostate cancer | Phase 1 Data readout | |
JANX008 (EGFR-TRACTr) Details Solid tumor/s, Cancer | Phase 1 Data readout |